Skip to main navigation

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact

News Releases

News Releases

Year

Mar 04, 2021

Fulcrum Therapeutics Announces CEO Transition

Feb 26, 2021

Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, March 4, 2021 at 8:00 a.m. ET

Feb 26, 2021

Fulcrum Therapeutics Recognizes Rare Disease Day 2021

Feb 19, 2021

Fulcrum Therapeutics to Participate in Upcoming Investor Conferences

Jan 22, 2021

Fulcrum Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Jan 19, 2021

Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock

Jan 19, 2021

Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock

Jan 19, 2021

Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer

Jan 06, 2021

Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Displaying 21 - 29 of 29

Investor Tools

Privacy Policy | EU Privacy Policy | Terms of use

Social Media Guidelines

Main Menu

About
Our Approach
Pipeline
- Publications
Therapeutic Focus
Careers
- Current Openings
- Faces of Fulcrum
Investor Relations
Contact